- Home
- HPP vs CADL Comparison
HPP vs CADL Comparison
Compare HPP & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPP
- CADL
- Stock Information
- Founded
- HPP 2009
- CADL 1999
- Country
- HPP United States
- CADL United States
- Employees
- HPP N/A
- CADL N/A
- Industry
- HPP Real Estate
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- HPP Finance
- CADL Health Care
- Exchange
- HPP Nasdaq
- CADL Nasdaq
- Market Cap
- HPP 374.6M
- CADL 306.4M
- IPO Year
- HPP 2010
- CADL 2021
- Fundamental
- Price
- HPP $2.29
- CADL $4.57
- Analyst Decision
- HPP Hold
- CADL Strong Buy
- Analyst Count
- HPP 10
- CADL 4
- Target Price
- HPP $3.32
- CADL $21.00
- AVG Volume (30 Days)
- HPP 3.1M
- CADL 1.1M
- Earning Date
- HPP 05-07-2025
- CADL 05-13-2025
- Dividend Yield
- HPP 2.19%
- CADL N/A
- EPS Growth
- HPP N/A
- CADL N/A
- EPS
- HPP N/A
- CADL N/A
- Revenue
- HPP $834,774,000.00
- CADL N/A
- Revenue This Year
- HPP N/A
- CADL N/A
- Revenue Next Year
- HPP $4.97
- CADL N/A
- P/E Ratio
- HPP N/A
- CADL N/A
- Revenue Growth
- HPP N/A
- CADL N/A
- 52 Week Low
- HPP $2.00
- CADL $3.79
- 52 Week High
- HPP $6.29
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- HPP 38.73
- CADL 32.96
- Support Level
- HPP $2.10
- CADL $4.25
- Resistance Level
- HPP $3.10
- CADL $5.33
- Average True Range (ATR)
- HPP 0.24
- CADL 0.47
- MACD
- HPP -0.03
- CADL -0.01
- Stochastic Oscillator
- HPP 26.36
- CADL 19.45
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.